Nuclear Medicine and Biology
Volume 33, Issue 4 , Pages 453-458 , May 2006

Development of 111In-labeled tumor-associated antigen peptides for monitoring dendritic-cell-based vaccination

  • Peter Laverman

      Affiliations

    • Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 24 3615054; fax: +31 24 3618942.
    • ,
  • I. Jolanda M. de Vries

      Affiliations

    • Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Nicole M. Scharenborg

      Affiliations

    • Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Annemiek de Boer

      Affiliations

    • Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Matthias Broekema

      Affiliations

    • Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Wim J.G. Oyen

      Affiliations

    • Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Carl G. Figdor

      Affiliations

    • Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Gosse J. Adema

      Affiliations

    • Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Otto C. Boerman

      Affiliations

    • Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands

Received 22 December 2005 ,Revised 18 January 2006 ,Accepted 26 February 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(06)00035-7

doi: 10.1016/j.nucmedbio.2006.02.005

Nuclear Medicine and Biology
Volume 33, Issue 4 , Pages 453-458 , May 2006

Article Tools

* Image Usage & Resolution